PTGS2 and Alzheimer disease: The EP2 receptor, which is downstream in the COX-2 signaling pathway and activated by prostaglandin-E2 (PGE2), is expressed in brain regions including hippocampus and cerebral cortex that are significantly affected in AD [43].